Penumbra, Inc. (PEN)

Penumbra Revenue

Penumbra had revenue of $410.15M in the quarter ending September 30, 2026, with 15.64% growth. This brings the company's total for the last twelve months to $1.56B, up 16.98% year-over-year. In the year 2025, Penumbra had annual revenue of $1.40B with 17.50% growth. That makes Penumbra the 5,862nd largest company in the world by revenue and 1,481st in the United States.

• Revenue (ttm): $1.56B
• Revenue Growth: +16.98%
• P/S Ratio: 8.06
• Revenue / Employee: $331,986
• Employees: 4,700
• Market Cap: 12.58B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Thrombectomy 947.92M 67.5%
• Embolization and Access 455.75M 32.5%

By Geography

Chart

• United States 1.09B 77.8%
• International 311.90M 22.2%

Fiscal year ended Dec 31, 2025 See the full Penumbra breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.40B	209.05M	17.50%
Dec 31, 2024	1.19B	136.09M	12.86%
Dec 31, 2023	1.06B	211.39M	24.95%
Dec 31, 2022	847.13M	99.54M	13.32%
Dec 31, 2021	747.59M	187.18M	33.40%
Dec 31, 2020	560.41M	13.01M	2.38%
Dec 31, 2019	547.41M	102.47M	23.03%
Dec 31, 2018	444.94M	111.17M	33.31%
Dec 31, 2017	333.76M	70.45M	26.75%
Dec 31, 2016	263.32M	77.22M	41.50%
Dec 31, 2015	186.10M	60.59M	48.27%
Dec 31, 2014	125.51M	36.66M	41.26%
Dec 31, 2013	88.85M	-	-

Data Source: Fiscal.ai Last updated: Oct 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error